Marksans Pharma consolidated net profit rises 29.26% in the June 2024 quarter
Sales rise 18.12% to Rs 590.62 crore
Net profit of Marksans Pharma rose 29.26% to Rs 88.75 crore in the quarter ended June 2024 as against Rs 68.66 crore during the previous quarter ended June 2023. Sales rose 18.12% to Rs 590.62 crore in the quarter ended June 2024 as against Rs 500.03 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales590.62500.03 18 OPM %21.7520.39 -PBDT140.46110.49 27 PBT120.0296.83 24 NP88.7568.66 29Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 14 2024 | 7:54 AM IST